Susan Richards

7.7k total citations · 2 hit papers
103 papers, 5.0k citations indexed

About

Susan Richards is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Immunology. According to data from OpenAlex, Susan Richards has authored 103 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hematology, 31 papers in Public Health, Environmental and Occupational Health and 28 papers in Immunology. Recurrent topics in Susan Richards's work include Acute Lymphoblastic Leukemia research (29 papers), Lysosomal Storage Disorders Research (23 papers) and Chronic Myeloid Leukemia Treatments (16 papers). Susan Richards is often cited by papers focused on Acute Lymphoblastic Leukemia research (29 papers), Lysosomal Storage Disorders Research (23 papers) and Chronic Myeloid Leukemia Treatments (16 papers). Susan Richards collaborates with scholars based in United States, United Kingdom and France. Susan Richards's co-authors include Anthony H. Goldstone, Jacob M. Rowe, Adele K. Fielding, Hillard M. Lazarus, Mark R. Litzow, David I. Marks, Selina M. Luger, Martin S. Tallman, Andrew McMillan and Georgina Buck and has published in prestigious journals such as The Lancet, Blood and Nature Biotechnology.

In The Last Decade

Susan Richards

100 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study

2006 591 citations Adele K. Fielding, Susan Richards et al. Blood profile →
In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)

2007 537 citations Anthony H. Goldstone, Susan Richards et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Susan Richards United States	35	2.1k	1.8k	1.1k	1.0k	895	103	5.0k
Jaap Jan Boelens Netherlands	49	822 0.4×	3.0k 1.7×	1.5k 1.3×	1.2k 1.2×	651 0.7×	276	7.3k
Eiichi Ishii Japan	42	881 0.4×	3.8k 2.1×	550 0.5×	1.1k 1.1×	487 0.5×	256	6.4k
Melvin H. Freedman Canada	35	417 0.2×	1.8k 1.0×	552 0.5×	1.6k 1.6×	449 0.5×	140	6.0k
Eveline S.J.M. de Bont Netherlands	39	583 0.3×	915 0.5×	263 0.2×	2.2k 2.2×	445 0.5×	122	5.0k
Henrik Sengeløv Denmark	36	499 0.2×	1.4k 0.8×	600 0.5×	1.9k 1.9×	195 0.2×	149	6.2k
Arnold I. Freeman United States	37	1.1k 0.5×	846 0.5×	146 0.1×	929 0.9×	542 0.6×	117	4.3k
Michael Bigby United States	30	603 0.3×	381 0.2×	284 0.3×	799 0.8×	253 0.3×	102	4.9k
Rodrigo T. Calado Brazil	36	460 0.2×	2.1k 1.2×	2.6k 2.3×	1.9k 1.9×	291 0.3×	191	6.3k
Neal S. Rote United States	39	853 0.4×	640 0.4×	284 0.3×	753 0.7×	455 0.5×	113	4.1k
Giovanni Migliaccio Italy	46	311 0.1×	2.4k 1.4×	1.2k 1.1×	2.5k 2.5×	346 0.4×	190	7.2k

Countries citing papers authored by Susan Richards

Since Specialization

Citations

This map shows the geographic impact of Susan Richards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Richards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Richards more than expected).

Fields of papers citing papers by Susan Richards

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Richards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Richards. The network helps show where Susan Richards may publish in the future.

Co-authorship network of co-authors of Susan Richards

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Richards. A scholar is included among the top collaborators of Susan Richards based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Richards. Susan Richards is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kronn, David, James Davison, Alexander Broomfield, et al.. (2025). The Mini-COMET Clinical Trial: Safety and Efficacy of Avalglucosidase Alfa after 97 Weeks of Treatment in Children with Infantile-Onset Pompe Disease Previously Treated with Alglucosidase Alfa. The Journal of Pediatrics. 285. 114664–114664.

Batista, Julie L., Ali Hariri, Manish Maski, et al.. (2024). Reduction in kidney function decline and risk of severe clinical events in agalsidase beta–treated Fabry disease patients: a matched analysis from the Fabry Registry. Clinical Kidney Journal. 17(8). sfae194–sfae194. 4 indexed citations

Hurbin, Fabrice, et al.. (2023). Pharmacokinetics of Alglucosidase Alfa Manufactured at the 4000‐L Scale in Participants with Pompe Disease: A Phase 3/4 Open‐Label Study. Clinical Pharmacology in Drug Development. 12(12). 1185–1193. 4 indexed citations

Ji, Allena, et al.. (2019). A Novel and Sensitive LC/MS/MS Method for Quantitation of Pyochelin in Human Sputum Samples from Cystic Fibrosis Patients. 3(1). 2 indexed citations

McGovern, Margaret M., Melissa Wasserstein, Brian Kirmse, et al.. (2015). Novel first-dose adverse drug reactions during a phase I trial of olipudase alfa (recombinant human acid sphingomyelinase) in adults with Niemann–Pick disease type B (acid sphingomyelinase deficiency). Genetics in Medicine. 18(1). 34–40. 46 indexed citations

Xu, Yuanxin, et al.. (2015). A breakthrough novel method to resolve the drug and target interference problem in immunogenicity assays. Journal of Immunological Methods. 426. 62–69. 64 indexed citations

Mason, Michael J., Leah Campbell, Nikola Zaharakis, Robin L. Foster, & Susan Richards. (2014). Levels of Teen Dating Violence and Substance Use in an Urban Emergency Department. Journal of Developmental & Behavioral Pediatrics. 35(9). 576–581. 8 indexed citations

Sørensen, Per Soelberg, Douglas L. Arnold, Jeffrey A. Cohen, et al.. (2013). Immunogenicity of Alemtuzumab Treatment in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients in the CARE-MS II Study (P07.101). Neurology. 80(7_supplement). 4 indexed citations

Strandberg, Kristi L., et al.. (2012). An Altered Immune Response, but Not Individual Cationic Antimicrobial Peptides, Is Associated with the Oral Attenuation of Ara4N-Deficient Salmonella enterica Serovar Typhimurium in Mice. PLoS ONE. 7(11). e49588–e49588. 13 indexed citations

10.

Richards, Susan, et al.. (2012). Cationic antimicrobial peptides serve as activation signals for the Salmonella Typhimurium PhoPQ and PmrAB regulons in vitro and in vivo. Frontiers in Cellular and Infection Microbiology. 2. 102–102. 45 indexed citations

11.

Wilcox, William R., Gabor E. Linthorst, Dominique P. Germain, et al.. (2011). Anti-α-galactosidase A antibody response to agalsidase beta treatment: Data from the Fabry Registry. Molecular Genetics and Metabolism. 105(3). 443–449. 57 indexed citations

12.

Abbott, Mary‐Alice, Sean N. Prater, Suhrad G. Banugaria, et al.. (2011). Atypical immunologic response in a patient with CRIM-negative Pompe disease. Molecular Genetics and Metabolism. 104(4). 583–586. 24 indexed citations

13.

Richards, Susan, et al.. (2011). Murine Antithymocyte Globulin T-Cell Depletion Is Mediated Predominantly by Macrophages, but the Fas/FasL Pathway Selectively Targets Regulatory T Cells. Transplantation. 92(5). 523–528. 14 indexed citations

14.

Goldstone, Anthony H., Susan Richards, Hillard M. Lazarus, et al.. (2007). In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood. 111(4). 1827–1833. 537 indexed citations breakdown →

15.

Gupta, Shalini, Stephen R. Indelicato, Thomas T. Kawabata, et al.. (2007). Recommendations for the design, optimization, and qualification of cell-based assays used for the detection of neutralizing antibody responses elicited to biological therapeutics. Journal of Immunological Methods. 321(1-2). 1–18. 161 indexed citations

16.

Gunn, John S. & Susan Richards. (2007). Recognition and Integration of Multiple Environmental Signals by the Bacterial Sensor Kinase PhoQ. Cell Host & Microbe. 1(3). 163–165. 13 indexed citations

17.

Chessells, Judith M., G Harrison, Susan Richards, et al.. (2002). Failure of a new protocol to improve treatment results in paediatric lymphoblastic leukaemia: lessons from the UK Medical Research Council trials UKALL X and UKALL XI. British Journal of Haematology. 118(2). 445–455. 18 indexed citations

18.

Paietta, Elisabeth, Donna Neuberg, Susan Richards, et al.. (2001). Rare adult acute lymphocytic leukemia with CD56 expression in the ECOG experience shows unexpected phenotypic and genotypic heterogeneity. American Journal of Hematology. 66(3). 189–196. 26 indexed citations

19.

Shepherd, Patricia, Susan Richards, & N. C. Allan. (1994). Severe cytopenias associated with the sequential use of busulphan and interferon‐alpha in chronic myeloid leukaemia. British Journal of Haematology. 86(1). 92–96. 11 indexed citations

20.

Secker‐Walker, Lorna M., et al.. (1989). Chromosomes and other prognostic factors in acute lymphoblastic leukaemia: a long‐term follow‐up. British Journal of Haematology. 72(3). 336–342. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact